Lite Strategy, Inc.
LITS
Rank in Stocks
#25027
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Share Price
$0.8467
Last synced: 2026-11-13
Market Cap
$28.08M
Change (1 day)
-6.64%
Change (1 year)
-58.08%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lite Strategy, Inc. (LITS)
Category
Healthcare
EPS for Lite Strategy, Inc. (LITS)
EPS as of September 2026 TTM: $-8.08
According to Lite Strategy, Inc.'s latest financial reports, its current EPS (TTM) is $-8.08. At the end of 2025 the company had an EPS of $-2.39, a decrease compared to its 2024 EPS of $2.67.
EPS history for Lite Strategy, Inc. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-8.08 | 238.08% |
| 2025 | $-2.39 | -189.51% |
| 2024 | $2.67 | -155.86% |
| 2023 | $-4.78 | -52.39% |
| 2022 | $-10.04 | -17.77% |
| 2021 | $-12.21 | 17.86% |
| 2020 | $-10.36 | 119.03% |
| 2019 | $-4.73 | -75.54% |
| 2018 | $-19.34 | -1,481.43% |
| 2017 | $1.40 | -111.48% |
| 2016 | $-12.20 | -47.37% |
| 2015 | $-23.18 | -14.15% |
| 2014 | $-27.00 | 22.73% |
| 2013 | $-22.00 | -67.26% |
| 2012 | $-67.20 | -37.08% |
| 2011 | $-106.80 | -16.82% |
| 2010 | $-128.40 | -28.67% |
| 2009 | $-180.00 | -16.67% |
| 2008 | $-216.00 | -18.18% |
| 2007 | $-264.00 | 69.23% |
| 2006 | $-156.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | -88.99% |
US
|
|
| $15.66 | -293.81% |
US
|
|
| $-7.07 | -12.50% |
US
|
|
| $-5.29 | -34.53% |
AU
|
|
| $12.73 | -257.58% |
BE
|
Questions about Lite Strategy, Inc.'s earnings per share (EPS)
What is Lite Strategy, Inc.'s earnings per share (EPS)?
Lite Strategy, Inc.'s earnings per share (EPS) over the last twelve months is $-8.08, as of Sep 2026.
What was Lite Strategy, Inc.'s earnings per share (EPS) in 2025?
In 2025, Lite Strategy, Inc.'s earnings per share (EPS) was $-2.39, compared with $2.67 in 2024.
How has Lite Strategy, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Lite Strategy, Inc.'s earnings per share (EPS) was highest in 2024 ($2.67) and lowest in 2021 ($-12.21).
How does Lite Strategy, Inc.'s earnings per share (EPS) compare with similar companies?
Lite Strategy, Inc.'s earnings per share (EPS) ($-8.08) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.